Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S4, 2018. DOI: 10.25251/skin.2.supp.4. Disponível em: https://skin.dermsquared.com/skin/article/view/252. Acesso em: 25 apr. 2026.